Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: A transnational study

European Journal of Clinical Pharmacology

Volumn 65, Issue 11, 2009, Pages 1113-1120

  Hallinan, Richard ^a   Crettol, Séverine ^b   Agho, Kingsley ^c   Attia, John ^d   Besson, Jacques ^e   Croquette Krokar, Marina ^f   Hämmig, Robert ^g   Déglon, Jean Jacques ^h   Byrne, Andrew ^a   Ray, John ⁱ   Somogyi, Andrew A ^j   Eap, Chin B ^b,k,l  

^a Byrne Surgery   (Australia)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g Psychiatrische Universitatsklinik   (Switzerland)

^h Fondation Phenix   (Switzerland)

ⁱ ST VINCENT S HOSPITAL   (Australia)

^j UNIVERSITY OF ADELAIDE   (Australia)

^k UNIVERSITY OF GENEVA   (Switzerland)

^l Hopital de Cery   (Switzerland)

more..

Author keywords

Benzodiazepine; Cannabis; Drug interaction; Enantiomer; Methadone; MMT; Pharmacokinetics

Indexed keywords

ALCOHOL; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; CANNABIS; CLONAZEPAM; CYTOCHROME P450 3A4; DIAMORPHINE; DIAZEPAM; FLUNITRAZEPAM; FLURAZEPAM; LORAZEPAM; METHADONE; MIDAZOLAM; OXAZEPAM; TRIAZOLAM;

ADULT; ARTICLE; DRUG ABUSE; DRUG ANTAGONISM; DRUG BLOOD LEVEL; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; TOBACCO;

EID: 70350240005     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-009-0706-8     Document Type: Article

References (45)

1. CB Eap T Buclin P Baumann 2002 Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence Clin Pharmacokinet 41 1153 1193 10.2165/00003088-200241140-00003 1:CAS:528:DC%2BD38XpsFKmsbc%3D 12405865
2. CB Eap M Bourquin JL Martin J Spagnoli S Livoti K Powell P Baumann JJ Déglon 2000 Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment Drug Alcohol Depend 61 47 54 10.1016/S0376-8716(00)00121-6 1:CAS:528:DC%2BD3cXovFaqt7s%3D 11064183 (Pubitemid 30813412)
3. S Crettol JJ Déglon J Besson M Croquette-Krokkar R Hämmig I Gothuey M Monnat CB Eap 2006 ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment Clin Pharmacol Ther 80 668 681 10.1016/j.clpt.2006.09.012 1:CAS:528:DC%2BD28Xhtleisb7K 17178267 (Pubitemid 44920225)
4. JK Coller DT Barratt K Dahlen MH Loennechen AA Somogyi 2006 ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals Clin Pharmacol Ther 80 682 690 10.1016/j.clpt.2006.09.011 1:CAS:528: DC%2BD28Xhtleisb7L 17178268 (Pubitemid 44920224)
5. AA Somogyi DT Barratt JK Coller 2007 Pharmacogenetics of opioids Clin Pharmacol Ther 81 429 444 10.1038/sj.clpt.6100095 1:CAS:528:DC%2BD2sXktl2lurk%3D 17339873 (Pubitemid 46364493)
6. S Crettol JJ Deglon A Besson M Croquette-Krokar R Hämmig I Gothuey M Monnat M Preisig CB Eap 2008 Association of dopamine and opioid receptor gene polymorphisms with response to methadone during maintenance treatment Prog Neuropsychopharmacol Biol Psychiatry 32 1722 1727 10.1016/j.pnpbp.2008.07.009 1:CAS:528:DC%2BD1cXhtFartLbN 18687376
7. RK Brooner VL King M Kidorf CW Schmidt Jr GE Bigelow 1997 Psychiatric and substance use comorbidity among treatment-seeking opioid abusers Arch Gen Psychiatry 54 71 80 1:STN:280:DyaK2s7lvFSlsA%3D%3D 9006403
8. P Clemmey R Brooner MA Chutuape M Kidorf M Stitzer 1997 Smoking habits and attitudes in a methadone maintenance treatment population Drug Alcohol Depend 44 123 132 10.1016/S0376-8716(96)01331-2 1:STN:280:DyaK2s3ktl2msQ%3D%3D 9088784 (Pubitemid 27129505)
9. A Bleich M Gelkopf V Schmidt R Hayward G Bodner M Adelson 1999 Correlates of benzodiazepine abuse in methadone maintenance treatment. A 1 year prospective study in an Israeli clinic Addiction 94 1533 1540 10.1046/j.1360-0443.1999.941015339.x 1:STN:280:DC%2BD3c3ltFGjsw%3D%3D 10790905 (Pubitemid 29481583)
10. J Hillebrand J Marsden E Finch J Strang 2001 Excessive alcohol consumption and drinking expectations among clients in methadone maintenance J Subst Abuse Treat 21 155 160 10.1016/S0740-5472(01)00198-2 1:STN:280: DC%2BD3Mnot12msA%3D%3D 11728789 (Pubitemid 33109064)
11. S Asnafi-Farhang P Hatchuel F Bourhis C Divine G Lagrue 2001 Prevalence of cannabis and tobacco use in patients attending a methadone center. Evaluation by urinary biomarkers Ann Med Interne (Paris) 152 Suppl. 3 IS37 IS42
12. M Backmund K Meyer C Henkel M Soyka J Reimer CG Schutz 2005 Co-consumption of benzodiazepines in heroin users, methadone-substituted and codeine-substituted patients J Addict Dis 24 17 29 10.1300/J069v24n04-02 16368654 (Pubitemid 43334176)
13. T Weizman M Gelkopf Y Melamed M Adelson A Bleich 2004 Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: a 1-year prospective study in an Israeli clinic Aust N Z J Psychiatry 38 42 46 14731193
14. S Nahvi K Richter X Li L Modali J Arnsten 2006 Cigarette smoking and interest in quitting in methadone maintenance patients Addict Behav 31 2127 2134 10.1016/j.addbeh.2006.01.006 16473476 (Pubitemid 44548179)
15. A Srivastava M Kahan S Ross 2008 The effect of methadone maintenance treatment on alcohol consumption: a systematic review J Subst Abuse Treat 34 215 223 10.1016/j.jsat.2007.04.001 17596906 (Pubitemid 351163516)
16. M Stenbacka O Beck A Leifman A Romelsjo A Helander 2007 Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment Drug Alcohol Rev 26 55 63 10.1080/09595230601036994 1:STN:280:DC%2BD2s7mtlCjtw%3D%3D 17364837
17. Hallinan R, Ray J, Agho K, Byrne A (2004) Correlations of (R)-methadone plasma concentrations in methadone maintenance (abstract). Presented the Australasian Professional Society on Alcohol and other Drugs (APSAD) Conference 2004. APSAD, Brisbane
18. KL Preston RR Griffiths EJ Cone WD Darwin CW Gorodetzky 1986 Diazepam and methadone blood levels following concurrent administration of diazepam and methadone Drug Alcohol Depend 18 195 202 10.1016/0376-8716(86)90051-7 1:CAS:528:DyaL2sXht1emsg%3D%3D 3096681 (Pubitemid 16002934)
19. SM Pond TG Tong NL Benowitz P Jacob III J Rigod 1982 Lack of effect of diazepam on methadone metabolism in methadone-maintained addicts Clin Pharmacol Ther 31 139 143 1:CAS:528:DyaL38XhsFCqurw%3D 7056020
20. R Spiga DB Huang RA Meisch J Grabowski 2001 Human methadone self-administration: effects of diazepam pretreatment Exp Clin Psychopharmacol 9 40 46 10.1037/1064-1297.9.1.40 1:CAS:528:DC%2BD3MXmtVKqtbY%3D 11519634
21. N Lintzeris TB Mitchell AJ Bond L Nestor J Strang 2007 Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients Drug Alcohol Depend 91 187 194 10.1016/j.drugalcdep.2007.05.019 1:CAS:528:DC%2BD2sXhtFKiu73N 17624687 (Pubitemid 47554601)
22. C Iribarne F Berthou S Baird Y Dréano D Picart JP Bail P Beaune JF Ménez 1996 Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes Chem Res Toxicol 9 365 373 10.1021/tx950116m 1:CAS:528:DyaK28XptFygsA%3D%3D 8839037 (Pubitemid 26079977)
23. R Hallinan J Ray A Byrne K Agho J Attia 2006 Therapeutic thresholds in methadone maintenance treatment: a receiver operating characteristic analysis Drug Alcohol Depend 81 129 136 10.1016/j.drugalcdep.2005.06.005 1:CAS:528:DC%2BD2MXhtlCrsL7J 16026938 (Pubitemid 41821796)
24. P Lawrinson J Copeland D Indig 2005 Development and validation of a brief instrument for routine outcome monitoring in opioid maintenance pharmacotherapy services: the brief treatment outcome measure (BTOM) Drug Alcohol Depend 80 125 133 10.1016/j.drugalcdep.2005.04.001 15869845 (Pubitemid 41266968)
25. DJR Foster AA Somogyi JM White F Bochner 2004 Population pharmacokinetics of ®)-, (S)- and rac-methadone in methadone maintenance patients Br J Clin Pharmacol 57 742 755 10.1111/j.1365-2125.2004.02079.x 1:CAS:528: DC%2BD2cXls1SisLw%3D 15151520 (Pubitemid 38748042)
26. Commonwealth of Australia (2001) Australian alcohol guidelines: health risk and benefits. National Health and Medical Research Council, Australia
27. S Crettol JJ Déglon J Besson M Croquette-Krokkar I Gothuey R Hämmig M Monnat H Hüttemann P Baumann CB Eap 2005 Methadone enantiomer plasma levels, CYP2B6, CYP2C19 and CYP2C9 genotypes, and response to treatment Clin Pharmacol Ther 78 593 604 10.1016/j.clpt.2005.08.011 1:CAS:528: DC%2BD2MXhtlShsLnP 16338275 (Pubitemid 41773635)
28. S Rudaz D Ortelli M Gex-Fabry JJ Deglon L Balant JL Veuthey 1999 Development of validated stereoselective methods for methadone determination in clinical samples Chirality 11 487 494 10.1002/(SICI)1520-636X(1999)11:5/ 6<487::AID-CHIR22>3.0.CO;2-3 1:CAS:528:DyaK1MXjsVOrsbc%3D 10419284 (Pubitemid 29247247)
29. S Souverain CB Eap JL Veuthey S Rudaz 2003 Automated LC-MS method for the fast stereoselective determination of methadone in plasma Clin Chem Lab Med 41 1615 1621 10.1515/CCLM.2003.245 1:CAS:528:DC%2BD2cXkt1yj 14708886 (Pubitemid 38055012)
30. Ansermot N, Rudaz S, Brawand-Amey M, Fleury-Souverain S, Veuthey JL, Eap CB (2009) Validation and long-term evaluation of a modified on-line chiral analytical method for therapeutic drug monitoring of ®, S)-methadone in clinical samples. J Chromatogr B 877:2301-2307
31. E Änggàrd LM Gunne J Holmstrand RE McMahon C-G Sandberg HR Sullivan 1975 Disposition of methadone in methadone maintenance Clin Pharmacol Ther 17 258 266 1120392
32. MI Nilsson E Änggàrd J Holmstrand LM Gunne 1982 Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase Eur J Clin Pharmacol 22 343 349 10.1007/BF00548404 1:STN:280:DyaL383mtFyiuw%3D%3D 7106170 (Pubitemid 12085323)
33. HJ Zhu JS Wang JS Markowitz JL Donovan BB Gibson HA Gefroh CL DeVane 2006 Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana J Pharmacol Exp Ther 317 850 857 10.1124/jpet.105.098541 1:CAS:528:DC%2BD28XktFalsro%3D 16439618
34. KR Dyer DJR Foster JM White AA Somogyi A Menelaou F Bochner 1999 Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships Clin Pharmacol Ther 65 685 694 10.1016/S0009-9236(99)90090-5 1:CAS:528:DyaK1MXktlCgtr0%3D 10391674 (Pubitemid 29294032)
35. KR Dyer JM White DJR Foster F Bochner A Menelaou AA Somogyi 2001 The relationship between mood state and plasma methadone concentration in maintenance patients J Clin Psychopharmacol 21 78 84 10.1097/00004714-200102000- 00014 1:CAS:528:DC%2BD3MXptlKktA%3D%3D 11199952 (Pubitemid 32096754)
36. TB Mitchell KR Dyer D Newcombe A Salter AA Somogyi F Bochner JM White 2004 Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure Br J Clin Pharmacol 58 609 617 10.1111/j.1365-2125.2004.02221.x 1:CAS:528: DC%2BD2MXms1Squw%3D%3D 15563359 (Pubitemid 39665148)
37. CB Eap S Crettol JS Rougier J Schlapfer GL Sintra JJ Deglon J Besson M Croquette-Krokar PA Carrupt H Abriel 2007 Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers Clin Pharmacol Ther 81 719 728 10.1038/sj.clpt.6100120 1:CAS:528:DC%2BD2sXlsFCqsbc%3D 17329992 (Pubitemid 46625109)
38. PS Calhoun WS Sampson HB Bosworth ME Feldman AC Kirby MA Hertzberg TP Wampler F Tate-Williams SD Moore JC Beckham 2000 Drug use and validity of substance use self-reports in veterans seeking help for posttraumatic stress disorder J Consult Clin Psychol 68 923 927 10.1037/0022-006X.68.5.923 1:STN:280:DC%2BD3crhtFOhtg%3D%3D 11068979
39. RD Weiss LM Najavits SF Greenfield JA Soto SR Shaw D Wyner 1998 Validity of substance use self-reports in dually diagnosed outpatients Am J Psychiatry 155 127 128 1:STN:280:DyaK1c%2FpsV2htw%3D%3D 9433351
40. KM Carroll 1995 Methodological issues and problems in the assessment of substance use Psychol Assess 7 349 358 10.1037/1040-3590.7.3.349
41. TF Babor J Brown FK DelBoca 1990 Validity of self-reports in applied research on addictive behaviors: fact or fiction? Behav Assess 12 5 31
42. E Digiusto V Seres A Bibby R Batey 1996 Concordance between urinalysis results and self-reported drug use by applicants for methadone maintenance in Australia Addict Behav 21 319 329 10.1016/0306-4603(95)00064-X 1:STN:280:DyaK2s%2Fjslymtw%3D%3D 8883483 (Pubitemid 26162228)
43. S Magura D Goldsmith C Casriel PJ Goldstein DS Lipton 1987 The validity of methadone clients' self-reported drug use Int J Addict 22 727 749 1:STN:280:DyaL1c%2FlslOkug%3D%3D 3679632
44. DA Zanis AT McLellan M Randall 1994 Can you trust patient self-reports of drug use during treatment? Drug Alcohol Depend 35 127 132 10.1016/0376-8716(94) 90119-8 1:STN:280:DyaK2czjtlSqsw%3D%3D 8055734 (Pubitemid 24154032)
45. B Kilpatrick M Howlett P Sedgwick AH Ghodse 2000 Drug use, self report and urinalysis Drug Alcohol Depend 58 111 116 10.1016/S0376-8716(99)00066-6 1:STN:280:DC%2BD3c7jt1Gntw%3D%3D 10669061